|
Leading Articles
What's in it for pharmacy? [more]
Curbing patients' expectations [more]
News & Features
News
Space, time and team working: issues for pharmacists
who wish to prescribe [more]
Delivering the new NHS: what the Budget and the Wanless
report mean [more]
Letters
Letters
to the Editor
Continuing Professional Development (CPD)
How to master interview skills
»(PDF*,
45K)
Article
How is the crisis in Zimbabwe affecting pharmacy in the country?
[more]
Features
How to treat hay fever and associated allergic conditions
in the pharmacy
»(PDF*,
60K)
Onlooker
Herb of Alexander /
Afghans suffering /
The alternatives /
Warning ignored? [more]
The Society
News
Council election: Questions for candidates
»(PDF*,
110K)
Council presentation: Getting the "Spoonful" message
across [more]
April Council meeting [more]
Obituaries & tributes [more]
Veterinary Pharmacists Group: Zoonotic risks in summer
months [more]
Official Notices
Annual general meeting [more]
Council voting papers [more]
Notice-board
Branch
meetings
Future
events
Conferences
and more
Products
|
Front Cover Picture
Following the recent publication of a consultation document about pharmacist
prescribing, Clare Bellingham looks at the issues that will have to be
addressed before pharmacists can prescribe. This week's front cover picture
(by Christopher Icha) illustrates our news
feature.
New advice on aspirin
The Committee on Safety of Medicines has recommended that aspirin should
be avoided
in children aged between 12 and 15 years if they are feverish.
NHS funding
In a news feature
Jonathan Buisson looks at the Wanless report, the Budget and the update
to the NHS plan, and what these documents mean for the National Health
Service and for pharmacy.
Treatment of hay fever
A special feature (PDF*
60K) provides an overview of hay fever and related allergic conditions
and their treatment.
Recalls
A batch of hydralazine
25mg tablets (Alpharma), in the livery of Cox pharmaceuticals, has been
recalled.
|
